Roche Diagnostics Corp.

FDA Regulatory Profile

Summary

Total Recalls
0
510(k) Clearances
445
Inspections
23
Compliance Actions
0

Known Names

roche diagnostics, roche diagnostics corporation, roche diagnostics operations

Recent 510(k) Clearances

K-NumberDeviceDate
K253490Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsFebruary 12, 2026
K253491ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integratedFebruary 12, 2026
K253839Elecsys Anti-SARS-CoV-2December 17, 2025
K253188CoaguChek XS Plus SystemOctober 24, 2025
K252163Elecsys Phospho-Tau (181P) PlasmaOctober 8, 2025
K242505Elecsys Cortisol IIIJuly 17, 2025
K250768Elecsys Anti-SARS-CoV-2June 10, 2025
K241453Elecsys sFlt-1 and Elecsys PlGFFebruary 7, 2025
K233060Elecsys Folate IIIJune 17, 2024
K220272cobas pulse blood glucose monitoring systemApril 26, 2024
K231927Elecsys PTH , Elecsys PTH STATMarch 22, 2024
K221890Elecsys Tg IISeptember 30, 2023
K222610Elecsys Anti-TgSeptember 15, 2023
K223637Elecsys proBNP II, Elecsys proBNP II STATJuly 21, 2023
K231348Elecsys ß-Amyloid (1-42) CSF II, Elecsys Total-Tau CSFJune 5, 2023
K220456Elecsys FT4 IVApril 7, 2023
K230161ONLINE TDM Phenytoin - Free Phenytoin applicationMarch 30, 2023
K221693Elecsys Anti-HCV II (08837031190)January 4, 2023
K221765ONLINE DAT Benzodiazepines IIDecember 23, 2022
K221842Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSFDecember 7, 2022